Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-045052
Filing Date
2013-08-13
Accepted
2013-08-13 13:52:19
Documents
10
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q v352348_10q.htm 10-Q 370591
2 EXHIBIT 31 v352348_ex31.htm EX-31 7663
3 EXHIBIT 32 v352348_ex32.htm EX-32 4800
4 GRAPHIC tlogo14.jpg GRAPHIC 47468
  Complete submission text file 0001144204-13-045052.txt   4613541

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT iccc-20130630.xml EX-101.INS 453670
6 XBRL TAXONOMY EXTENSION SCHEMA iccc-20130630.xsd EX-101.SCH 34159
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE iccc-20130630_cal.xml EX-101.CAL 50080
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE iccc-20130630_def.xml EX-101.DEF 145764
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE iccc-20130630_lab.xml EX-101.LAB 207960
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iccc-20130630_pre.xml EX-101.PRE 185279
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 131032473
SIC: 2835 In Vitro & In Vivo Diagnostic Substances